BioNexus Gene Lab CorpNASDAQ:BGLCNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.3050
- TODAY'S CHANGE (%)0.0131 (4.4878%)
- Bid / Lots0.3000/ 1
- Ask / Lots0.3100/ 28
- Open / Previous Close0.3000 / 0.2919
- Day Range
- 52 Week Range
- Volume29,163
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | BGLC |
|---|---|---|
| 09:35 ET | 1000 | 0.3 |
| 09:39 ET | 1000 | 0.2968 |
| 09:42 ET | 1925 | 0.29 |
| 09:55 ET | 1728 | 0.29 |
| 10:13 ET | 200 | 0.29 |
| 10:27 ET | 121 | 0.29 |
| 10:36 ET | 748 | 0.2935 |
| 10:44 ET | 2295 | 0.3 |
| 10:54 ET | 107 | 0.3 |
| 10:56 ET | 1000 | 0.2933 |
| 11:21 ET | 150 | 0.2866 |
| 11:39 ET | 100 | 0.287 |
| 11:54 ET | 2000 | 0.2933 |
| 11:59 ET | 350 | 0.293241 |
| 12:26 ET | 700 | 0.2999 |
| 12:57 ET | 13493 | 0.3 |
| 01:00 ET | 100 | 0.303 |
| 01:20 ET | 1448 | 0.305 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
BioNexus Gene Lab Corp | 5.2M | -7.8x | --- |
Syros Pharmaceuticals Inc | 7.0M | -0.1x | --- |
Jaguar Health Inc | 9.1M | -0.1x | --- |
Medicure Inc | 6.6M | -3.2x | --- |
LakeShore Biopharma Co Ltd | 49.0M | -0.5x | --- |
Rosetta Genomics Ltd | 590.0 | 0.0x | --- |
Company Information
BioNexus Gene Lab Corporation is a Malaysia-based company, which provides ribonucleic acid (RNA)-based genomic diagnostics. The Company provides a molecular lab that is focused on the application of functional genomics to enable early detection of infectious diseases and cancers. The Company operates in the biochemical industry segment through its two Malaysian subsidiaries, MRNA Scientific Malaysia and Chemrex. MRNA Scientific Malaysia owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which the Company uses in its business. The Company's non-invasive blood screening tests analyze changes in RNA to coronavirus, dengue, human immunodeficiency virus (HIV), human papillomavirus (HPV) and the risk potentiality of cancer diseases. Chemrex is a wholesaler of industrial chemicals for the manufacture of industrial, medical, appliance, aero, automotive, mechanical and electronic industries in Asean region.
Contact Information
- Headquarters
- Tower B, Vertical Business Suite, 10-2,KUALA LUMPUR, Malaysia 59200
- Phone
- ---
- Fax
- ---
Executives
- Chairman of the Board
- Min Fong Yeat
- President, Chief Executive Officer, Acting Chief Financial Officer, Chief Operating Officer
- Lee Su-Leng Tan
- Director
- Chi Yuen Leong
- Director
- Meng Wong Yee
- Independent Director
- Jook Low
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.2M |
|---|---|
Revenue (TTM) | $9.3M |
Shares Outstanding | 18.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.81 |
EPS | $-0.04 |
Book Value | $0.55 |
P/E Ratio | -7.8x |
Price/Sales (TTM) | 0.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -9.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
